Company news from the 10/21/05 News Brief
Phoenix Group Holdings, a medical education holding company, has been named as one of the 50 fastest growing companies in New Jersey by the weekly business publication NJBIZ.
Bayer and Amgen's Onyx subsidiary announce an oncology drug failed a Phase-III trial goal among liver cancer patients.
A survey of patients found greater prescription drug adherence among patients who received a free 30-day sample in addition to a prescription.
Sanofi and the firm with which it's co-developing alirocumab disclosed that regulators want some patients to be assessed for neurocognitive side effects.